Finance

Lists
B1SX34:BVMF
Boston Scientific Corp Brazilian Depositary Receipt
R$ ५३.३४
०.००%
(०.००) 1D
अक्टोबर ९, १६:५६:०० GMT-३  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for B1SX34...
Open
R$ ५२.७२
High
R$ ५३.३४
Low
R$ ५२.५०
Mkt. cap
६३.५३ अरब
Avg. vol.
१.०२ हजार
Volume
६७.००
52-wk high
R$ १४०.९१
52-wk low
R$ ५०.२९
Shares outstanding
१.४५ अरब
No. of employees
५९ हजार
Open
R$ ५२.७२
High
R$ ५३.३४
Low
R$ ५२.५०
Mkt. cap
६३.५३ अरब
Avg. vol.
१.०२ हजार
Volume
६७.००
52-wk high
R$ १४०.९१
52-wk low
R$ ५०.२९
Shares outstanding
१.४५ अरब
No. of employees
५९ हजार
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
१५ घण्टा पहिले
Boston Scientific stock costs EUR 38.37, volume is 7.4 percent of average
ad-hoc-news.de
ad-hoc-news.de
·
१ दिन पहिले
Boston Scientific stock pre-market at EUR 38.21
Yahoo Finance
Yahoo Finance
·
३ दिन पहिले
Why Boston Scientific (BSX) Outpaced the Stock Market Today
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries. BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp Brazilian Depositary Receipt
CEOMichael F. Mahoney
Employees५९ हजार
Founded१९७९ जुन २९
HeadquartersMarlborough, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
५.०६ अरब
५.२९ अरब
५.२० अरब
५.४४ अरब
Cost of goods sold
१.५४ अरब
१.६१ अरब
१.६० अरब
१.६१ अरब
Cost of revenue
१.५४ अरब
१.६१ अरब
१.६० अरब
१.६१ अरब
Research and development expenses
५१.४० करोड
५६.९० करोड
५१.६० करोड
५५.४० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.७४ अरब
१.८३ अरब
१.७८ अरब
१.८० अरब
Operating expense
२.४८ अरब
२.६३ अरब
२.५३ अरब
२.५९ अरब
Total operating expenses
४.०२ अरब
४.२४ अरब
४.१३ अरब
४.२० अरब
Operating income
१.०५ अरब
१.०४ अरब
१.०७ अरब
१.२५ अरब
Other non operating income
-१.६० करोड
२.८० करोड
२.८० करोड
-६०.०० लाख
EBT including unusual items
९३.८० करोड
७०.०० करोड
१.१६ अरब
१.०६ अरब
EBT excluding unusual items
९३.५० करोड
१.०१ अरब
९९.९० करोड
१.१४ अरब
Income tax expense
१८.३० करोड
३.०० करोड
-१७.६० करोड
१५.५० करोड
Effective tax rate
१९.५१%
४.२९%
-१५.१३%
१४.६२%
Other operating expenses
-
-
-
-
Net income
७५.५० करोड
६७.२० करोड
१.३४ अरब
९०.७० करोड
Net profit margin
१४.९१%
१२.७१%
२५.७७%
१६.६७%
Earnings per share
०.७५
०.८०
०.८०
०.८६
Interest and investment income
-
२.९० करोड
-
१.१० करोड
Interest expense
-८.७० करोड
-९.०० करोड
-९.०० करोड
-९.६० करोड
Net interest expenses
-८.७० करोड
-६.१० करोड
-९.०० करोड
-८.५० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१.३९ अरब
१.४१ अरब
१.४२ अरब
१.६० अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू